| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 6.4e-05 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 4.3e-05 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -6.6e-05 | 1 |